EUCTR2018-002650-67-ES
Active, not recruiting
Phase 1
Comparison of the efficacy of autologous platelet rich plasma injections, andextracorporeal shock wave therapy, in the treatment of work –related lateralepicondylitis. - Efficacy of PRP injections, and extracorporeal shock wave therapy, in occupational
Ibermutuamur (Mutua Colaboradora con la Seguridad Social nº 274)0 sites66 target enrollmentAugust 10, 2018
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- The epicondylitis is an overuse injury, in most cases, is a self-limited course andresponds well to conservative treatment. Its etiology is degenerative and is relatedto a repetitive overuse and underlying tendinopathy.
- Sponsor
- Ibermutuamur (Mutua Colaboradora con la Seguridad Social nº 274)
- Enrollment
- 66
- Status
- Active, not recruiting
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\- Workers diagnosed with work\-related epicondylitis (ICD 9\-CM code 726\.32\) as the primary diagnosis, receiving healthcare in Ibermutuamur. \- Age equal or greater than 18 years. \- Patients receive this diagnosis after being explored: painful sensitivity to pressure on the epicondyle; Cozen maneuver; chair test; and
- •radiological examination. \- Does not present remission of symptoms after a period of approximately 25 days of conservative treatment that include oral medication, local cold, functional relative rest and rehabilitation.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range 66
- •F.1\.3 Elderly (\>\=65 years) no
- •F.1\.3\.1 Number of subjects for this age range
Exclusion Criteria
- •\- Patients with cervical pathology. \- With posterior interosseous neuropathy. \- With any kind (unless cancer pathology hospital discharge) cancer. \- Patients with mental health problems that prevent them from successfully follow rehabilitation treatment. \- Patients with thrombocytopenia. \- Patients who have pacemakers. \- Clotting problems or anticoagulant therapy. \- Rheumatoid arthritis diagnosed. \- Pregnant or breast\-feeding patients. \- Treatment with deposit costicoesteroid infiltrations in the last 6 weeks
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Comparing the beneficial effects of patients own Platelet rich plasma therapy and topical minoxidil 5%lotion in males with hairloss problems due to male hormones.CTRI/2020/05/025389Jawaharlal Institute of Postgraduate Medical Education and Research
Not yet recruiting
Not Applicable
Comparison between autologous platelet rich fibrin and autologous platelet rich plasma in myringoplasty.Health Condition 1: O- Medical and SurgicalCTRI/2022/09/045567Vinayaka mission medical college
Recruiting
Not Applicable
Assessment the effect of using autologous platelet rich plasma (PRP) in prevention of hypertrophic scarIRCT20201007048955N2Clinical Research Development Center50
Recruiting
Not Applicable
Impact of platelet-rich plasma on anal fissureIRCT20201225049826N1Shahid Beheshti University of Medical Sciences60
Not yet recruiting
Not Applicable
Efficacy of autologous platelet rich plasma (PRP) in prevention of hypertrophic scarIRCT20201007048955N1Clinical Research Development Center50